Generic Staywell Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.30 Cr
About Generic Staywell
Generic Staywell Private Limited (GSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2019 (Six years and one month 5 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.30 Cr.
Amit Rana and Sukh Singh serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51200HP2019PTC007313
- Company No.
007313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2019
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Generic Staywell Private Limited offer?
Generic Staywell Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs.
Who are the key members and board of directors at Generic Staywell?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Rana  | Director | 18-Jan-2019 | Current |
| Sukh Singh | Director | 18-Jan-2019 | Current |
Financial Performance of Generic Staywell.
Generic Staywell Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Generic Staywell?
In 2020, Generic Staywell had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unisrv Remedies Private LimitedSukh Singh is a mutual person
Charges (Loans)
₹13.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2020 | Others | ₹1.30 Cr | Open |
How Many Employees Work at Generic Staywell?
Unlock and access historical data on people associated with Generic Staywell, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Generic Staywell, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generic Staywell's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.